Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials

Wolf, 1991, Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer, N Engl J Med, 324, 1685, 10.1056/NEJM199106133242402 Forastiere, 2013, Long-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer, J Clin Oncol, 31, 845, 10.1200/JCO.2012.43.6097 Lefebvre, 1996, Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial, JNCI J Natl Cancer Inst, 88, 890, 10.1093/jnci/88.13.890 Hoffman, 2006, Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival, The Laryngoscope, 116, 1, 10.1097/01.mlg.0000236095.97947.26 Gourin, 2009, The Effect of treatment on survival in patients with advanced laryngeal carcinoma: Laryngeal Cancer and Survival, The Laryngoscope, 119, 1312, 10.1002/lary.20477 Lorch, 2011, Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial, LancetOncol., 12, 153 Hitt, 2014, A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer, Ann Oncol, 25, 216, 10.1093/annonc/mdt461 Eisbruch, 1996, Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer, J Clin Oncol, 14, 2322, 10.1200/JCO.1996.14.8.2322 Withers, 1988, The hazard of accelerated tumor clonogen repopulation during radiotherapy, Acta Oncol, 27, 131, 10.3109/02841868809090333 Urba, 2006, Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm, J Clin Oncol, 24, 593, 10.1200/JCO.2005.01.2047 Wolf, 2017, Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer, JAMAOtolaryngol Head Neck Surg, 143, 355 Microvascular Committee of the American Academy of Otolaryngology-Head & Neck Surgery, 2019, Salvage laryngectomy and laryngopharyngectomy: multicenter review of outcomes associated with a reconstructive approach, Head Neck., 41, 16, 10.1002/hed.25192 Forastiere, 2003, Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer, N Engl J Med, 349, 2091, 10.1056/NEJMoa031317 Swiecicki, 2019, A randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor, J Clin Oncol, 37, 6066, 10.1200/JCO.2019.37.15_suppl.6066 Risch, 2019, J Clin Oncol, 37, e17539, 10.1200/JCO.2019.37.15_suppl.e17539 Zou, 2005, Regularization and variable selection via the elastic net, J R Stat Soc: Ser B (Stat Method)., 67, 301, 10.1111/j.1467-9868.2005.00503.x Luo, 2019, Development of a fully cross-validated Bayesian network approach for local control prediction in lung cancer, IEEE Trans Radiat Plasma Med Sci, 3, 232, 10.1109/TRPMS.2018.2832609 Collins, 2015, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement, BMJ (Clin Res ed), 350 Johansen, 2003, Laryngeal carcinoma–multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy, Acta Oncol, 42, 771, 10.1080/02841860310017595 Ho, 2018, Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer, JAMAOncololgy, 4, 985 Mascarella, 2018, Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: a systematic review and meta-analysis, Head Neck, 40, 1091, 10.1002/hed.25075 Cho, 2018, Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study, BMC Cancer, 18, 10.1186/s12885-018-4876-6 Haddad, 2015, Neutrophil-to-lymphocyte ratio in head and neck cancer, J Med Imaging Radiat Oncol, 59, 514, 10.1111/1754-9485.12305 Tham, 2018, Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis, Head Neck, 40, 2546, 10.1002/hed.25324 Simpson, 2018, Primary cancer vs competing causes of death in survivors of head and neck cancer, JAMAOncology, 4, 257 Baxi, 2014, Causes of death in long-term survivors of head and neck cancer, Cancer, 120, 1507, 10.1002/cncr.28588 Mell, 2019, Nomogram to predict the benefit of intensive treatment for locoregionally advanced head and neck cancer, Clin Cancer Res, 25, 7078, 10.1158/1078-0432.CCR-19-1832 Hatakenaka, 2011, Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy, Int J Radiat Oncol Biol Phys, 81, 339, 10.1016/j.ijrobp.2010.05.051 Lambrecht, 2014, Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma, Radiother Oncol, 110, 429, 10.1016/j.radonc.2014.01.004 Cao, 2019, Predictive values of MRI and PET derived quantitative parameters for patterns of failure in both p16+ and p16- high risk head and neck cancer, Front Oncol, 9, 10.3389/fonc.2019.01118 Driessen, 2016, Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas, Head Neck, 38, E613, 10.1002/hed.24051 de Perrot, 2017, Apparent diffusion coefficient histograms of human papillomavirus-positive and human papillomavirus-negative head and neck squamous cell carcinoma: assessment of tumor heterogeneity and comparison with histopathology, AJNR Am J Neuroradiol, 38, 2153, 10.3174/ajnr.A5370 Cao, 2008, Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study, Int J Radiat Oncol Biol Phys, 72, 1287, 10.1016/j.ijrobp.2008.08.024 Hermans, 2003, Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy, Int J Radiat Oncol Biol Phys, 57, 1351, 10.1016/S0360-3016(03)00764-8 Schwartz, 2015, Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522, Int J Radiat Oncol Biol Phys, 91, 721, 10.1016/j.ijrobp.2014.12.023 Kikuchi, 2015, Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status, Head Neck, 37, 1524, 10.1002/hed.23784 Floberg, 2018, Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging, Head & Neck, 40, 2280, 10.1002/hed.25337 Moan, 2019, The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status, Radiother Oncol, 140, 54, 10.1016/j.radonc.2019.05.019 Chepeha, 2009, Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy, Head Neck, 31, 452, 10.1002/hed.21006 de Bree, 2017, Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond, Head & Neck, 39, 2329, 10.1002/hed.24883 Spector, 2019, Prognostic value of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma, JAMAOtolaryngol Head Neck Surg, 145, 1012 Stransky, 2011, The mutational landscape of head and neck squamous cell carcinoma, Science, 333, 1157, 10.1126/science.1208130